ELMSFORD, N.Y. & MINNEAPOLIS--(BUSINESS WIRE)--Feb. 27, 2006--BioScrip, Inc. (Nasdaq: BIOS) announced today that the Company's Chief Executive Officer, Henry F. Blissenbach, will retire upon the expiration of his contract, effective June 30, 2006. BioScrip Executive Chairman, Richard H. Friedman will assume the role of interim Chief Executive Officer at that time, while the Company's board of directors identifies a replacement. Mr. Blissenbach will serve as a consultant to the Company for one year following the end of his contract. Mr. Friedman will become more active in daily operations as Mr. Blissenbach completes his tenure.
